VIDEO: Alcon pharmaceutical division focuses on glaucoma, dry eye
Click Here to Manage Email Alerts
NASHVILLE, Tenn. — Alcon’s U.S. pharmaceutical division shared its focus on glaucoma and dry eye with attendees at Optometry’s Meeting.
“We are continuing to look for innovation around dry eye disease and glaucoma,” Lisa Praeger, general manager for U.S. pharmaceutical and dry eye at Alcon, said in this Healio video.
Products highlighted at the meeting include Rhopressa (netarsudil ophthalmic solution 0.02%), Rocklatan (netarsudil 0.02%/latanoprost 0.005% ophthalmic solution), Simbrinza (brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension) and Eysuvis (loteprednol etabonate ophthalmic suspension 0.25%) for dry eye flare.
In addition, the company recently launched Alcon Science, which provides up-to-date information about new innovations, and also had made its medical science liaisons available for science conversations, she said.
Collapse
Healio Interviews
Read more about
Click Here to Manage Email Alerts